Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer.
about
Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast CancerTriple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer.The prevalence of BRCA1/2 mutations of triple-negative breast cancer patients in Xinjiang multiple ethnic region of China.Breast and Ovarian Cancer Risk due to Prevalence of BRCA1 and BRCA2 Variants in Pakistani Population: A Pakistani Database Report.Prevalence of PALB2 mutations in breast cancer patients in multi-ethnic Asian population in Malaysia and Singapore.JF-305, a pancreatic cancer cell line is highly sensitive to the PARP inhibitor olaparib.Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countriesEvaluation of the BOADICEA risk assessment model in women with a family history of breast cancer.Accuracy of BRCA1/2 mutation prediction models for different ethnicities and genders: experience in a southern Chinese cohort.Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancerHigh prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.Characterization of BRCA1 and BRCA2 variants in multi-ethnic Asian cohort from a Malaysian case-control studyPatterns and functional implications of rare germline variants across 12 cancer typesHaplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations.Prevalence of BRCA1 and BRCA2 Germline Mutations in Breast Cancer Women of Multiple Ethnic Region in Northwest China.Hereditary breast cancer in the Han Chinese population.Molecular genetics analysis of hereditary breast and ovarian cancer patients in India.Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis.BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.Evaluating the performance of National Comprehensive Cancer Network (NCCN) breast and ovarian genetic/familial high risk assessment referral criteria for breast cancer women in an Asian surgical breast clinic.The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study.Performance of BRCA1/2 mutation prediction models in male breast cancer patients.A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.BRCA1 germ-line mutations and tumor characteristics in eastern Chinese women with familial breast cancer.Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history.Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia.Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory.
P2860
Q27023165-CB8FEA26-607B-4D2C-928C-26C63F052B0FQ33739351-D0283847-568A-40A0-A4CF-7F5B4A7A9782Q33826713-DC34EEAE-FF49-482E-8A8C-CF18900B24A5Q34923121-12B0BFAE-D4A0-4340-A971-25D12CAD5462Q34974233-B37DA550-9416-44A6-9811-E4CC4BD9722FQ34993640-E6D66FFE-4103-49A4-957A-EC62F347D3C9Q35695425-368906CF-D3F7-4DFE-BFB2-95FB2681C3B6Q35815711-0A24EF2F-09C1-4FFA-823E-22631A944A74Q35823504-8EA3ECD2-C4BF-41BA-A8B6-19C75B052755Q35916576-470E8FFB-A4F8-4770-A4CF-1290960D4D24Q36110709-B7108D42-B430-4F59-B6A2-6DBB96071AB6Q36245632-D24D7FEF-37DB-4FCD-BC0D-9286F5E1EFD3Q36286700-C09D34F4-6050-422E-993E-44B30AD95A4CQ36437964-28CE951C-3004-4833-9032-02D3844A315CQ36543070-5FD085FE-DCF3-4F18-92AC-F76E61F3002CQ36763992-95A257E0-B1DE-4036-94FD-41307622EA59Q36978755-7983C07B-3C9E-4395-BE58-A3DE98810CE7Q37316299-A15417EC-60D7-45DD-99FF-BE9A0FADD098Q37418120-8A30A099-75FC-4813-BC91-A82A50D0AD6AQ37507410-CC29F0D7-456D-44BA-BE55-D54F17C93558Q37626899-B81B9F87-B123-4752-A41E-A289294043F8Q38456659-FB45A69E-3467-49D9-B332-928534A3EB57Q38739022-156A3BA5-8BEE-498F-B825-7DCB87A87A36Q42181679-3EA78E5C-3DFC-4B36-B15C-8FE5FBA1C4ADQ44367712-1D32A7C9-F0DB-4A3C-83C9-4982251363A9Q44717730-279763F0-6D22-4801-97CF-4BBF7283334CQ47586106-9842223F-EB3C-4F10-A032-EF79FD61C6BEQ50728624-0988B51D-7F1B-4FF1-B98F-F1E98CDAECCD
P2860
Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Evaluation of BRCA1 and BRCA2 ...... ow incidence of breast cancer.
@en
type
label
Evaluation of BRCA1 and BRCA2 ...... ow incidence of breast cancer.
@en
prefLabel
Evaluation of BRCA1 and BRCA2 ...... ow incidence of breast cancer.
@en
P2093
P2860
P356
P1476
Evaluation of BRCA1 and BRCA2 ...... ow incidence of breast cancer.
@en
P2093
E Thirthagiri
N A Mohd Taib
P2860
P2888
P356
10.1186/BCR2118
P577
2008-07-16T00:00:00Z
P5875
P6179
1038704105